Log In
BCIQ
Print this Print this
 

cefiderocol (S-649266)

  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionParenteral siderophore cephalosporin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat Gram-negative bacterial infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/28/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today